224 related articles for article (PubMed ID: 33264710)
1. Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study.
Low A; Su L; Stefaniak JD; Mak E; Dounavi ME; Muniz-Terrera G; Ritchie K; Ritchie CW; Markus HS; O'Brien JT
Neurobiol Aging; 2021 Feb; 98():124-133. PubMed ID: 33264710
[TBL] [Abstract][Full Text] [Related]
2. Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study.
Low A; Prats-Sedano MA; McKiernan E; Carter SF; Stefaniak JD; Nannoni S; Su L; Dounavi ME; Muniz-Terrera G; Ritchie K; Lawlor B; Naci L; Malhotra P; Mackay C; Koychev I; Ritchie CW; Markus HS; O'Brien JT
Alzheimers Res Ther; 2022 Oct; 14(1):154. PubMed ID: 36224605
[TBL] [Abstract][Full Text] [Related]
3. CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study.
Low A; Prats-Sedano MA; Stefaniak JD; McKiernan EF; Carter SF; Douvani ME; Mak E; Su L; Stupart O; Muniz G; Ritchie K; Ritchie CW; Markus HS; O'Brien JT
J Neurol Neurosurg Psychiatry; 2022 May; 93(5):481-490. PubMed ID: 35135868
[TBL] [Abstract][Full Text] [Related]
4. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
Low A; Ng KP; Chander RJ; Wong B; Kandiah N
J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
[TBL] [Abstract][Full Text] [Related]
5. Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer's disease.
Stefaniak JD; Su L; Mak E; Sheikh-Bahaei N; Wells K; Ritchie K; Waldman A; Ritchie CW; O'Brien JT
Alzheimers Dement; 2018 Feb; 14(2):253-258. PubMed ID: 29156222
[TBL] [Abstract][Full Text] [Related]
6. Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults.
Ten Kate M; Sanz-Arigita EJ; Tijms BM; Wink AM; Clerigue M; Garcia-Sebastian M; Izagirre A; Ecay-Torres M; Estanga A; Villanua J; Vrenken H; Visser PJ; Martinez-Lage P; Barkhof F
Neurobiol Aging; 2016 Feb; 38():14-20. PubMed ID: 26827639
[TBL] [Abstract][Full Text] [Related]
7. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
Vipin A; Kumar D; Soo SA; Zailan FZ; Leow YJ; Koh CL; Ng ASL; Ng KP; Kandiah N
Alzheimers Res Ther; 2023 Jun; 15(1):103. PubMed ID: 37270543
[TBL] [Abstract][Full Text] [Related]
8. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.
Rojas S; Brugulat-Serrat A; Bargalló N; Minguillón C; Tucholka A; Falcon C; Carvalho A; Morán S; Esteller M; Gramunt N; Fauria K; Camí J; Molinuevo JL; Gispert JD
J Cereb Blood Flow Metab; 2018 Feb; 38(2):250-261. PubMed ID: 28492093
[TBL] [Abstract][Full Text] [Related]
9. Parental History of Dementia Is Associated with Increased Small Vessel Cerebrovascular Disease.
Stamm BC; Lao PJ; Rizvi B; Colon J; Igwe K; Chesebro AG; Maas B; Schupf N; Mayeux R; Manly JJ; Brickman AM
J Gerontol A Biol Sci Med Sci; 2020 Oct; 75(11):2156-2161. PubMed ID: 31838489
[TBL] [Abstract][Full Text] [Related]
10. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Microbleeds and White Matter Hyperintensities are Associated with Cognitive Decline in an Asian Memory Clinic Study.
Gyanwali B; Lui B; Tan CS; Chong EJY; Vrooman H; Chen C; Hilal S
Curr Alzheimer Res; 2021; 18(5):399-413. PubMed ID: 34420506
[TBL] [Abstract][Full Text] [Related]
12. APOE4 and Confluent White Matter Hyperintensities Have a Synergistic Effect on Episodic Memory Impairment in Prodromal Dementia.
Kumar D; Yatawara C; Wang B; Wong B; Tan YJ; Zailan FZ; Ng KP; Kandiah N
J Alzheimers Dis; 2022; 87(3):1103-1114. PubMed ID: 35431245
[TBL] [Abstract][Full Text] [Related]
13. White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease.
Adluru N; Destiche DJ; Lu SY; Doran ST; Birdsill AC; Melah KE; Okonkwo OC; Alexander AL; Dowling NM; Johnson SC; Sager MA; Bendlin BB
Neuroimage Clin; 2014; 4():730-42. PubMed ID: 24936424
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for and Clinical Relevance of Incident and Progression of Cerebral Small Vessel Disease Markers in an Asian Memory Clinic Population.
Gyanwali B; Shaik MA; Tan BY; Venketasubramanian N; Chen C; Hilal S
J Alzheimers Dis; 2019; 67(4):1209-1219. PubMed ID: 30714960
[TBL] [Abstract][Full Text] [Related]
15. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
[TBL] [Abstract][Full Text] [Related]
16. Proximity to dementia onset and multi-modal neuroimaging changes: The prevent-dementia study.
Mak E; Dounavi ME; Low A; Carter SF; McKiernan E; Williams GB; Jones PS; Carriere I; Muniz GT; Ritchie K; Ritchie C; Su L; O'Brien JT
Neuroimage; 2021 Apr; 229():117749. PubMed ID: 33454416
[TBL] [Abstract][Full Text] [Related]
17. DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease.
Sala-Vila A; Arenaza-Urquijo EM; Sánchez-Benavides G; Suárez-Calvet M; Milà-Alomà M; Grau-Rivera O; González-de-Echávarri JM; Crous-Bou M; Minguillón C; Fauria K; Operto G; Falcón C; Salvadó G; Cacciaglia R; Ingala S; Barkhof F; Schröder H; Scarmeas N; Gispert JD; Molinuevo JL;
Am J Clin Nutr; 2021 Jun; 113(6):1627-1635. PubMed ID: 33733657
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype.
Haan MN; Aiello AE; West NA; Jagust WJ
Neurobiol Aging; 2008 Dec; 29(12):1774-82. PubMed ID: 17540481
[TBL] [Abstract][Full Text] [Related]
19. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.
Xia Y; Shen Y; Wang Y; Yang L; Wang Y; Li Y; Liang X; Zhao Q; Wu J; Chu S; Liang Z; Wang X; Qiu B; Ding H; Ding D; Cheng X; Dong Q
Aging (Albany NY); 2020 May; 12(9):8506-8522. PubMed ID: 32388497
[TBL] [Abstract][Full Text] [Related]
20. White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer's disease that emerge prior to dementia.
Schoemaker D; Zanon Zotin MC; Chen K; Igwe KC; Vila-Castelar C; Martinez J; Baena A; Fox-Fuller JT; Lopera F; Reiman EM; Brickman AM; Quiroz YT
Alzheimers Res Ther; 2022 Jun; 14(1):89. PubMed ID: 35768838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
